{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T17:55:52Z","timestamp":1795110952933,"version":"4.10.3"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T00:00:00Z","timestamp":1708041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T00:00:00Z","timestamp":1708041600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Beijing Bethune Public Welfare Foundation","award":["EBS:2159000087"],"award-info":[{"award-number":["EBS:2159000087"]}]},{"DOI":"10.13039\/100018904","name":"Beijing Xisike Clinical Oncology Research Foundation","doi-asserted-by":"publisher","award":["EBS:2159000015"],"award-info":[{"award-number":["EBS:2159000015"]}],"id":[{"id":"10.13039\/100018904","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Immunotherapy brings new hope to patients with advanced gastric cancer. However, liver metastases can reduce the efficacy of immunotherapy in patients. Tumor-associated macrophages (TAMs) may be the cause of this reduction in efficacy. SPP1\u2009+\u2009TAMs are considered to have immunosuppressive properties. We aimed to investigate the involvement of SPP1\u2009+\u2009TAMs in the metastasis of gastric cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The single-cell transcriptome was combined with batched BULK datasets for analysis. Animal models were used to verify the analysis results.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We reveal the interaction of SPP1\u2009+\u2009TAMs with CD8\u2009+\u2009exhausted T cells in metastatic cancer. Among these interactions, GDF15-TGFBR2 may play a key immunosuppressive role. We constructed an LR score to quantify interactions based on ligands and receptors. The LR score is highly correlated with various immune features and clinical molecular subtypes. The LR score may also guide the prediction of the efficacy of immunotherapy and prognosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The crosstalk between SPP1\u2009+\u2009TAMs and CD8\u2009+\u2009exhausted T cells plays a key immunosuppressive role in the gastric metastatic cancer microenvironment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical Abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1186\/s12967-023-04688-1","type":"journal-article","created":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T00:02:13Z","timestamp":1708041733000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":93,"title":["Potential crosstalk between SPP1\u2009+\u2009TAMs and CD8\u2009+\u2009exhausted T cells promotes an immunosuppressive environment in gastric metastatic cancer"],"prefix":"10.1186","volume":"22","author":[{"given":"Yan","family":"Du","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yilin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sen","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bozhi","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingjiang","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanlong","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,16]]},"reference":[{"issue":"10251","key":"4688_CR1","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/s0140-6736(20)31288-5","volume":"396","author":"EC Smyth","year":"2020","unstructured":"Smyth EC, Nilsson M, Grabsch HI, et al. Gastric cancer. Lancet. 2020;396(10251):635\u201348. https:\/\/doi.org\/10.1016\/s0140-6736(20)31288-5.","journal-title":"Lancet"},{"issue":"3","key":"4688_CR2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, et al. GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"4688_CR3","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21657","author":"SS Joshi","year":"2021","unstructured":"Joshi SS, Badgwell BD. Current treatment and recent progress in gastric cancer. Cancer J Clin. 2021. https:\/\/doi.org\/10.3322\/caac.21657.","journal-title":"Cancer J Clin"},{"issue":"8","key":"4688_CR4","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1002\/cac2.12193","volume":"41","author":"FH Wang","year":"2021","unstructured":"Wang FH, Zhang XT, Li YF, et al. The chinese society of clinical oncology (CSCO): clinical guidelines for the diagnosis and treatment of gastric cancer, 2021. Cancer Commun. 2021;41(8):747\u201395. https:\/\/doi.org\/10.1002\/cac2.12193.","journal-title":"Cancer Commun"},{"issue":"1","key":"4688_CR5","doi-asserted-by":"publisher","first-page":"4840","DOI":"10.1038\/s41467-021-25122-4","volume":"12","author":"D Na","year":"2021","unstructured":"Na D, Chae J, Cho SY, et al. Predictive biomarkers for 5-fluorouracil and oxaliplatin-based chemotherapy in gastric cancers via profiling of patient-derived xenografts. Nat Commun. 2021;12(1):4840. https:\/\/doi.org\/10.1038\/s41467-021-25122-4.","journal-title":"Nat Commun"},{"issue":"7","key":"4688_CR6","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.3748\/wjg.v20.i7.1635","volume":"20","author":"M Orditura","year":"2014","unstructured":"Orditura M, Galizia G, Sforza V, et al. Treatment of gastric cancer. World J Gastroenterol. 2014;20(7):1635\u201349. https:\/\/doi.org\/10.3748\/wjg.v20.i7.1635.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"4688_CR7","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s40880-019-0349-9","volume":"39","author":"FH Wang","year":"2019","unstructured":"Wang FH, Shen L, Li J, et al. The Chinese society of clinical oncology (CSCO): clinical guidelines for the diagnosis and treatment of gastric cancer. Cancer Commun. 2019;39(1):10. https:\/\/doi.org\/10.1186\/s40880-019-0349-9.","journal-title":"Cancer Commun"},{"issue":"1","key":"4688_CR8","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s40880-019-0372-x","volume":"39","author":"K Gao","year":"2019","unstructured":"Gao K, Wu J. National trend of gastric cancer mortality in China (2003\u20132015): a population-based study. Cancer communications. 2019;39(1):24. https:\/\/doi.org\/10.1186\/s40880-019-0372-x.","journal-title":"Cancer communications"},{"issue":"328","key":"4688_CR9","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1126\/scitranslmed.aad7118","volume":"8","author":"W Zou","year":"2016","unstructured":"Zou W, Wolchok JD, Chen L. PD-L1 (B7\u2013H1) and PD-1 pathway blockade for cancer therapy: mechanisms, response biomarkers, and combinations. Sci Trans Med. 2016;8(328):328. https:\/\/doi.org\/10.1126\/scitranslmed.aad7118.","journal-title":"Sci Trans Med"},{"issue":"8","key":"4688_CR10","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1056\/NEJMoa1003466","volume":"363","author":"FS Hodi","year":"2010","unstructured":"Hodi FS, O\u2019Day SJ, McDermott DF, et al. Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med. 2010;363(8):711\u201323. https:\/\/doi.org\/10.1056\/NEJMoa1003466.","journal-title":"N Engl J Med"},{"issue":"4","key":"4688_CR11","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1158\/2159-8290.Cd-20-1680","volume":"11","author":"P Sharma","year":"2021","unstructured":"Sharma P, Siddiqui BA, Anandhan S, et al. The next decade of immune checkpoint therapy. Cancer Discov. 2021;11(4):838\u201357. https:\/\/doi.org\/10.1158\/2159-8290.Cd-20-1680.","journal-title":"Cancer Discov"},{"issue":"18","key":"4688_CR12","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1200\/jco.19.03296","volume":"38","author":"S Fukuoka","year":"2020","unstructured":"Fukuoka S, Hara H, Takahashi N, et al. regorafenib plus nivolumab in patients with advanced gastric or colorectal cancer: an open-label, dose-escalation, and dose-expansion phase Ib trial (REGONIVO, EPOC1603). J Clin Oncol Off J Am Soc Clin Oncol. 2020;38(18):2053\u201361. https:\/\/doi.org\/10.1200\/jco.19.03296.","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"10111","key":"4688_CR13","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1016\/s0140-6736(17)31827-5","volume":"390","author":"YK Kang","year":"2017","unstructured":"Kang YK, Boku N, Satoh T, et al. Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2017;390(10111):2461\u201371. https:\/\/doi.org\/10.1016\/s0140-6736(17)31827-5.","journal-title":"Lancet"},{"issue":"10294","key":"4688_CR14","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/s0140-6736(21)00797-2","volume":"398","author":"YY Janjigian","year":"2021","unstructured":"Janjigian YY, Shitara K, Moehler M, et al. First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial. Lancet. 2021;398(10294):27\u201340. https:\/\/doi.org\/10.1016\/s0140-6736(21)00797-2.","journal-title":"Lancet"},{"issue":"7890","key":"4688_CR15","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/s41586-021-04161-3","volume":"600","author":"YY Janjigian","year":"2021","unstructured":"Janjigian YY, Kawazoe A, Ya\u00f1ez P, et al. The KEYNOTE-811 trial of dual PD-1 and HER2 blockade in HER2-positive gastric cancer. Nature. 2021;600(7890):727\u201330. https:\/\/doi.org\/10.1038\/s41586-021-04161-3.","journal-title":"Nature"},{"issue":"20","key":"4688_CR16","doi-asserted-by":"publisher","first-page":"7613","DOI":"10.1002\/cam4.3417","volume":"9","author":"Y Kundel","year":"2020","unstructured":"Kundel Y, Sternschuss M, Moore A, et al. Efficacy of immune-checkpoint inhibitors in metastatic gastric or gastroesophageal junction adenocarcinoma by patient subgroups: a systematic review and meta-analysis. Cancer Med. 2020;9(20):7613\u201325. https:\/\/doi.org\/10.1002\/cam4.3417.","journal-title":"Cancer Med"},{"issue":"5","key":"4688_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.112437","volume":"42","author":"Q Luo","year":"2023","unstructured":"Luo Q, Dong Z, Xie W, et al. Apatinib remodels the immunosuppressive tumor ecosystem of gastric cancer enhancing anti-PD-1 immunotherapy. Cell Rep. 2023;42(5): 112437. https:\/\/doi.org\/10.1016\/j.celrep.2023.112437.","journal-title":"Cell Rep"},{"issue":"8","key":"4688_CR18","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/s41568-021-00366-w","volume":"21","author":"D Bayik","year":"2021","unstructured":"Bayik D, Lathia JD. Cancer stem cell-immune cell crosstalk in tumour progression. Nat Rev Cancer. 2021;21(8):526\u201336. https:\/\/doi.org\/10.1038\/s41568-021-00366-w.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"4688_CR19","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/s41591-020-1131-x","volume":"27","author":"J Yu","year":"2021","unstructured":"Yu J, Green MD, Li S, et al. Liver metastasis restrains immunotherapy efficacy via macrophage-mediated T cell elimination. Nat Med. 2021;27(1):152\u201364. https:\/\/doi.org\/10.1038\/s41591-020-1131-x.","journal-title":"Nat Med"},{"issue":"10","key":"4688_CR20","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1001\/jamaoncol.2019.2187","volume":"5","author":"SL Topalian","year":"2019","unstructured":"Topalian SL, Hodi FS, Brahmer JR, et al. Five-year survival and correlates among patients with advanced melanoma, renal cell carcinoma, or non-small cell lung cancer treated with nivolumab. JAMA Oncol. 2019;5(10):1411\u201320. https:\/\/doi.org\/10.1001\/jamaoncol.2019.2187.","journal-title":"JAMA Oncol"},{"issue":"5","key":"4688_CR21","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1158\/2326-6066.Cir-16-0325","volume":"5","author":"PC Tumeh","year":"2017","unstructured":"Tumeh PC, Hellmann MD, Hamid O, et al. Liver metastasis and treatment outcome with anti-PD-1 monoclonal antibody in patients with melanoma and NSCLC. Cancer Immunol Res. 2017;5(5):417\u201324. https:\/\/doi.org\/10.1158\/2326-6066.Cir-16-0325.","journal-title":"Cancer Immunol Res"},{"issue":"1","key":"4688_CR22","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/nri978","volume":"3","author":"S Gordon","year":"2003","unstructured":"Gordon S. Alternative activation of macrophages. Nat Rev Immunol. 2003;3(1):23\u201335. https:\/\/doi.org\/10.1038\/nri978.","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"4688_CR23","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.cell.2021.01.010","volume":"184","author":"S Cheng","year":"2021","unstructured":"Cheng S, Li Z, Gao R, et al. A pan-cancer single-cell transcriptional atlas of tumor infiltrating myeloid cells. Cell. 2021;184(3):792-809.e23. https:\/\/doi.org\/10.1016\/j.cell.2021.01.010.","journal-title":"Cell"},{"key":"4688_CR24","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-000778","author":"EM Garrido-Martin","year":"2020","unstructured":"Garrido-Martin EM, Mellows TWP, Clarke J, et al. M1(hot) tumor-associated macrophages boost tissue-resident memory T cells infiltration and survival in human lung cancer. J Immunother Cancer. 2020. https:\/\/doi.org\/10.1136\/jitc-2020-000778.","journal-title":"J Immunother Cancer"},{"issue":"9","key":"4688_CR25","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1016\/j.celrep.2016.04.084","volume":"15","author":"AM Georgoudaki","year":"2016","unstructured":"Georgoudaki AM, Prokopec KE, Boura VF, et al. Reprogramming tumor-associated macrophages by antibody targeting inhibits cancer progression and metastasis. Cell Rep. 2016;15(9):2000\u201311. https:\/\/doi.org\/10.1016\/j.celrep.2016.04.084.","journal-title":"Cell Rep"},{"issue":"1","key":"4688_CR26","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1038\/s41467-022-29366-6","volume":"13","author":"J Qi","year":"2022","unstructured":"Qi J, Sun H, Zhang Y, et al. Single-cell and spatial analysis reveal interaction of FAP(+) fibroblasts and SPP1(+) macrophages in colorectal cancer. Nat Commun. 2022;13(1):1742. https:\/\/doi.org\/10.1038\/s41467-022-29366-6.","journal-title":"Nat Commun"},{"issue":"2","key":"4688_CR27","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.730","volume":"12","author":"H Jiang","year":"2022","unstructured":"Jiang H, Yu D, Yang P, et al. Revealing the transcriptional heterogeneity of organ-specific metastasis in human gastric cancer using single-cell RNA Sequencing. Clin Transl Med. 2022;12(2): e730. https:\/\/doi.org\/10.1002\/ctm2.730.","journal-title":"Clin Transl Med"},{"issue":"5","key":"4688_CR28","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1016\/j.cell.2015.05.002","volume":"161","author":"EZ Macosko","year":"2015","unstructured":"Macosko EZ, Basu A, Satija R, et al. Highly parallel genome-wide expression profiling of individual cells using nanoliter droplets. Cell. 2015;161(5):1202\u201314. https:\/\/doi.org\/10.1016\/j.cell.2015.05.002.","journal-title":"Cell"},{"issue":"3","key":"4688_CR29","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1158\/2159-8290.Cd-21-0683","volume":"12","author":"V Kumar","year":"2022","unstructured":"Kumar V, Ramnarayanan K, Sundar R, et al. Single-cell atlas of lineage states, tumor microenvironment, and subtype-specific expression programs in gastric cancer. Cancer Discov. 2022;12(3):670\u201391. https:\/\/doi.org\/10.1158\/2159-8290.Cd-21-0683.","journal-title":"Cancer Discov"},{"issue":"4","key":"4688_CR30","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/nbt.2859","volume":"32","author":"C Trapnell","year":"2014","unstructured":"Trapnell C, Cacchiarelli D, Grimsby J, et al. The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells. Nat Biotechnol. 2014;32(4):381\u20136. https:\/\/doi.org\/10.1038\/nbt.2859.","journal-title":"Nat Biotechnol"},{"issue":"4","key":"4688_CR31","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1038\/s41596-020-0292-x","volume":"15","author":"M Efremova","year":"2020","unstructured":"Efremova M, Vento-Tormo M, Teichmann SA, et al. Cell PhoneDB: inferring cell-cell communication from combined expression of multi-subunit ligand-receptor complexes. Nat Protoc. 2020;15(4):1484\u2013506. https:\/\/doi.org\/10.1038\/s41596-020-0292-x.","journal-title":"Nat Protoc"},{"issue":"1","key":"4688_CR32","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/s41467-021-21246-9","volume":"12","author":"S Jin","year":"2021","unstructured":"Jin S, Guerrero-Juarez CF, Zhang L, et al. Inference and analysis of cell-cell communication using cell chat. Nat Commun. 2021;12(1):1088. https:\/\/doi.org\/10.1038\/s41467-021-21246-9.","journal-title":"Nat Commun"},{"issue":"10","key":"4688_CR33","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1038\/s41591-018-0136-1","volume":"24","author":"P Jiang","year":"2018","unstructured":"Jiang P, Gu S, Pan D, et al. Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response. Nat Med. 2018;24(10):1550\u20138. https:\/\/doi.org\/10.1038\/s41591-018-0136-1.","journal-title":"Nat Med"},{"key":"4688_CR34","doi-asserted-by":"publisher","unstructured":"Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014. 513 7517 202 209. https:\/\/doi.org\/10.1038\/nature13480","DOI":"10.1038\/nature13480"},{"issue":"3","key":"4688_CR35","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1136\/gutjnl-2019-320368","volume":"70","author":"M Zhang","year":"2021","unstructured":"Zhang M, Hu S, Min M, et al. Dissecting transcriptional heterogeneity in primary gastric adenocarcinoma by single cell RNA sequencing. Gut. 2021;70(3):464\u201375. https:\/\/doi.org\/10.1136\/gutjnl-2019-320368.","journal-title":"Gut"},{"issue":"1","key":"4688_CR36","doi-asserted-by":"publisher","first-page":"6619","DOI":"10.1038\/s41467-022-34395-2","volume":"13","author":"H Luo","year":"2022","unstructured":"Luo H, Xia X, Huang LB, et al. Pan-cancer single-cell analysis reveals the heterogeneity and plasticity of cancer-associated fibroblasts in the tumor microenvironment. Nat Commun. 2022;13(1):6619. https:\/\/doi.org\/10.1038\/s41467-022-34395-2.","journal-title":"Nat Commun"},{"issue":"9","key":"4688_CR37","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.imbio.2014.05.002","volume":"219","author":"DY Vogel","year":"2014","unstructured":"Vogel DY, Glim JE, Stavenuiter AW, et al. Human macrophage polarization in vitro: maturation and activation methods compared. Immunobiology. 2014;219(9):695\u2013703. https:\/\/doi.org\/10.1016\/j.imbio.2014.05.002.","journal-title":"Immunobiology"},{"issue":"1","key":"4688_CR38","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/ni.3324","volume":"17","author":"F Ginhoux","year":"2016","unstructured":"Ginhoux F, Schultze JL, Murray PJ, et al. New insights into the multidimensional concept of macrophage ontogeny, activation and function. Nat Immunol. 2016;17(1):34\u201340. https:\/\/doi.org\/10.1038\/ni.3324.","journal-title":"Nat Immunol"},{"issue":"21","key":"4688_CR39","doi-asserted-by":"publisher","first-page":"11514","DOI":"10.1073\/pnas.94.21.11514","volume":"94","author":"MR Bootcov","year":"1997","unstructured":"Bootcov MR, Bauskin AR, Valenzuela SM, et al. MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily. Proc Natl Acad Sci USA. 1997;94(21):11514\u20139. https:\/\/doi.org\/10.1073\/pnas.94.21.11514.","journal-title":"Proc Natl Acad Sci USA"},{"key":"4688_CR40","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-002787","author":"Z Wang","year":"2021","unstructured":"Wang Z, He L, Li W, et al. GDF15 induces immunosuppression via CD48 on regulatory T cells in hepatocellular carcinoma. J Immunother Cancer. 2021. https:\/\/doi.org\/10.1136\/jitc-2021-002787.","journal-title":"J Immunother Cancer"},{"issue":"11","key":"4688_CR41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0078618","volume":"8","author":"Z Zhou","year":"2013","unstructured":"Zhou Z, Li W, Song Y, et al. Growth differentiation factor-15 suppresses maturation and function of dendritic cells and inhibits tumor-specific immune response. PLoS ONE. 2013;8(11): e78618. https:\/\/doi.org\/10.1371\/journal.pone.0078618.","journal-title":"PLoS ONE"},{"issue":"1","key":"4688_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2021.112522","volume":"402","author":"Y Gao","year":"2021","unstructured":"Gao Y, Xu Y, Zhao S, et al. Growth differentiation factor-15 promotes immune escape of ovarian cancer via targeting CD44 in dendritic cells. Exp Cell Res. 2021;402(1): 112522. https:\/\/doi.org\/10.1016\/j.yexcr.2021.112522.","journal-title":"Exp Cell Res"},{"issue":"4","key":"4688_CR43","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.ccell.2018.03.012","volume":"33","author":"DS Thommen","year":"2018","unstructured":"Thommen DS, Schumacher TN. T cell dysfunction in cancer. Cancer Cell. 2018;33(4):547\u201362. https:\/\/doi.org\/10.1016\/j.ccell.2018.03.012.","journal-title":"Cancer Cell"},{"key":"4688_CR44","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.715234","volume":"12","author":"JS Dolina","year":"2021","unstructured":"Dolina JS, Van Braeckel-Budimir N, Thomas GD, et al. CD8(+) T cell exhaustion in cancer. Front Immunol. 2021;12: 715234. https:\/\/doi.org\/10.3389\/fimmu.2021.715234.","journal-title":"Front Immunol"},{"issue":"1","key":"4688_CR45","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41588-020-00752-4","volume":"53","author":"C Valero","year":"2021","unstructured":"Valero C, Lee M, Hoen D, et al. The association between tumor mutational burden and prognosis is dependent on treatment context. Nat Genet. 2021;53(1):11\u20135. https:\/\/doi.org\/10.1038\/s41588-020-00752-4.","journal-title":"Nat Genet"},{"issue":"6","key":"4688_CR46","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1001\/jamaoncol.2021.0275","volume":"7","author":"J Chao","year":"2021","unstructured":"Chao J, Fuchs CS, Shitara K, et al. Assessment of pembrolizumab therapy for the treatment of microsatellite instability-high gastric or gastroesophageal junction cancer among patients in the KEYNOTE-059, KEYNOTE-061, and KEYNOTE-062 Clinical Trials. JAMA Oncol. 2021;7(6):895\u2013902. https:\/\/doi.org\/10.1001\/jamaoncol.2021.0275.","journal-title":"JAMA Oncol"},{"issue":"1","key":"4688_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2020.100036","volume":"6","author":"F Pietrantonio","year":"2021","unstructured":"Pietrantonio F, Randon G, Di Bartolomeo M, et al. Predictive role of microsatellite instability for PD-1 blockade in patients with advanced gastric cancer: a meta-analysis of randomized clinical trials. ESMO open. 2021;6(1): 100036. https:\/\/doi.org\/10.1016\/j.esmoop.2020.100036.","journal-title":"ESMO open"},{"issue":"156","key":"4688_CR48","doi-asserted-by":"publisher","first-page":"15640","DOI":"10.1126\/scitranslmed.3004504","volume":"4","author":"H Zouridis","year":"2012","unstructured":"Zouridis H, Deng N, Ivanova T, et al. Methylation subtypes and large-scale epigenetic alterations in gastric cancer. Sci Trans Med. 2012;4(156):15640. https:\/\/doi.org\/10.1126\/scitranslmed.3004504.","journal-title":"Sci Trans Med"},{"issue":"4","key":"4688_CR49","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.ccell.2018.03.010","volume":"33","author":"Y Liu","year":"2018","unstructured":"Liu Y, Sethi NS, Hinoue T, et al. Comparative molecular analysis of gastrointestinal adenocarcinomas. Cancer Cell. 2018;33(4):721-35.e8. https:\/\/doi.org\/10.1016\/j.ccell.2018.03.010.","journal-title":"Cancer Cell"},{"key":"4688_CR50","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.omtn.2021.03.023","volume":"24","author":"Q Meng","year":"2021","unstructured":"Meng Q, Lu YX, Ruan DY, et al. DNA methylation regulator-mediated modification patterns and tumor microenvironment characterization in gastric cancer. Mol Therapy Nucl acids. 2021;24:695\u2013710. https:\/\/doi.org\/10.1016\/j.omtn.2021.03.023.","journal-title":"Mol Therapy Nucl acids"},{"issue":"5","key":"4688_CR51","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/nm.3850","volume":"21","author":"R Cristescu","year":"2015","unstructured":"Cristescu R, Lee J, Nebozhyn M, et al. Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes. Nat Med. 2015;21(5):449\u201356. https:\/\/doi.org\/10.1038\/nm.3850.","journal-title":"Nat Med"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-023-04688-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-023-04688-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-023-04688-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,19]],"date-time":"2024-02-19T03:07:43Z","timestamp":1708312063000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-023-04688-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,16]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["4688"],"URL":"https:\/\/doi.org\/10.1186\/s12967-023-04688-1","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,16]]},"assertion":[{"value":"24 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors report that there are no competing interests to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"158"}}